Katerina Kechris
Concepts (503)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Disease, Chronic Obstructive | 21 | 2026 | 923 | 3.010 |
Why?
| | Metabolomics | 16 | 2024 | 727 | 2.800 |
Why?
| | DNA Methylation | 23 | 2026 | 683 | 2.660 |
Why?
| | Algorithms | 14 | 2025 | 1839 | 2.070 |
Why?
| | Software | 14 | 2026 | 692 | 2.060 |
Why?
| | Genome-Wide Association Study | 11 | 2024 | 1407 | 2.020 |
Why?
| | Computational Biology | 9 | 2025 | 681 | 2.000 |
Why?
| | Gene Expression Profiling | 20 | 2025 | 1786 | 1.770 |
Why?
| | Sequence Analysis, RNA | 9 | 2021 | 442 | 1.700 |
Why?
| | Proteomics | 5 | 2026 | 1195 | 1.690 |
Why?
| | Bayes Theorem | 10 | 2023 | 433 | 1.650 |
Why?
| | MicroRNAs | 11 | 2026 | 701 | 1.640 |
Why?
| | High-Throughput Nucleotide Sequencing | 5 | 2021 | 550 | 1.420 |
Why?
| | Mass Spectrometry | 6 | 2022 | 750 | 1.410 |
Why?
| | Genomics | 7 | 2025 | 836 | 1.350 |
Why?
| | Quantitative Trait Loci | 15 | 2024 | 374 | 1.300 |
Why?
| | Gene Regulatory Networks | 6 | 2025 | 320 | 1.250 |
Why?
| | Gene Expression Regulation | 13 | 2025 | 2609 | 1.210 |
Why?
| | Smoking | 9 | 2025 | 1472 | 1.170 |
Why?
| | Data Interpretation, Statistical | 5 | 2020 | 372 | 1.170 |
Why?
| | Prenatal Exposure Delayed Effects | 13 | 2025 | 675 | 1.120 |
Why?
| | Autoimmunity | 12 | 2026 | 927 | 1.110 |
Why?
| | Polymorphism, Single Nucleotide | 11 | 2024 | 2147 | 1.100 |
Why?
| | Islets of Langerhans | 9 | 2026 | 833 | 1.050 |
Why?
| | Models, Genetic | 7 | 2019 | 536 | 1.050 |
Why?
| | Phenotype | 21 | 2024 | 3164 | 0.960 |
Why?
| | Oligonucleotide Array Sequence Analysis | 6 | 2021 | 758 | 0.890 |
Why?
| | Adiposity | 10 | 2024 | 543 | 0.870 |
Why?
| | Diabetes Mellitus, Type 1 | 15 | 2026 | 3890 | 0.830 |
Why?
| | Gene Expression | 10 | 2021 | 1490 | 0.820 |
Why?
| | Brain | 9 | 2024 | 2941 | 0.800 |
Why?
| | Transcriptome | 10 | 2025 | 1046 | 0.780 |
Why?
| | Epigenesis, Genetic | 13 | 2026 | 685 | 0.750 |
Why?
| | Metabolome | 5 | 2024 | 384 | 0.730 |
Why?
| | Computer Simulation | 9 | 2025 | 1026 | 0.720 |
Why?
| | Databases, Factual | 6 | 2021 | 1486 | 0.710 |
Why?
| | Emphysema | 4 | 2023 | 100 | 0.700 |
Why?
| | Models, Statistical | 5 | 2020 | 682 | 0.670 |
Why?
| | Propensity Score | 1 | 2023 | 367 | 0.660 |
Why?
| | Ethanol | 5 | 2020 | 627 | 0.640 |
Why?
| | Conserved Sequence | 3 | 2009 | 245 | 0.630 |
Why?
| | Maternal Exposure | 6 | 2024 | 213 | 0.620 |
Why?
| | Pediatric Obesity | 7 | 2024 | 638 | 0.610 |
Why?
| | Humans | 101 | 2026 | 144957 | 0.610 |
Why?
| | Biomarkers | 21 | 2026 | 4275 | 0.610 |
Why?
| | Pulmonary Emphysema | 6 | 2023 | 275 | 0.610 |
Why?
| | User-Computer Interface | 1 | 2020 | 165 | 0.600 |
Why?
| | Machine Learning | 2 | 2024 | 587 | 0.590 |
Why?
| | RNA | 4 | 2021 | 940 | 0.560 |
Why?
| | Fluorocarbons | 4 | 2023 | 143 | 0.550 |
Why?
| | Fetal Blood | 10 | 2024 | 342 | 0.530 |
Why?
| | Health Status | 1 | 2023 | 836 | 0.520 |
Why?
| | Genetic Predisposition to Disease | 12 | 2025 | 2365 | 0.500 |
Why?
| | Linear Models | 4 | 2019 | 854 | 0.500 |
Why?
| | Female | 68 | 2026 | 78376 | 0.490 |
Why?
| | ROC Curve | 5 | 2020 | 615 | 0.480 |
Why?
| | Models, Theoretical | 1 | 2020 | 582 | 0.480 |
Why?
| | Case-Control Studies | 16 | 2026 | 3608 | 0.470 |
Why?
| | Hypnotics and Sedatives | 1 | 2018 | 216 | 0.470 |
Why?
| | Alcoholism | 3 | 2020 | 817 | 0.460 |
Why?
| | Animals | 34 | 2023 | 38109 | 0.450 |
Why?
| | Glycosphingolipids | 1 | 2015 | 7 | 0.450 |
Why?
| | Seroconversion | 3 | 2026 | 49 | 0.440 |
Why?
| | CpG Islands | 7 | 2024 | 165 | 0.430 |
Why?
| | Drosophila | 3 | 2010 | 166 | 0.430 |
Why?
| | Environmental Pollutants | 3 | 2023 | 167 | 0.420 |
Why?
| | Placenta | 5 | 2023 | 780 | 0.410 |
Why?
| | Interleukin-16 | 1 | 2013 | 6 | 0.410 |
Why?
| | Pregnancy | 22 | 2025 | 7191 | 0.410 |
Why?
| | Nitrogenase | 2 | 2013 | 11 | 0.400 |
Why?
| | Male | 54 | 2026 | 72406 | 0.390 |
Why?
| | Smoking Cessation | 1 | 2017 | 439 | 0.390 |
Why?
| | Schistosomiasis japonica | 3 | 2022 | 34 | 0.380 |
Why?
| | Transcription, Genetic | 3 | 2018 | 1496 | 0.380 |
Why?
| | Markov Chains | 2 | 2020 | 129 | 0.380 |
Why?
| | Multivariate Analysis | 2 | 2013 | 1540 | 0.380 |
Why?
| | Mice | 19 | 2022 | 18365 | 0.370 |
Why?
| | DNA | 3 | 2019 | 1464 | 0.370 |
Why?
| | Sample Size | 3 | 2023 | 123 | 0.360 |
Why?
| | Genotype | 6 | 2020 | 1835 | 0.360 |
Why?
| | RNA, Messenger | 7 | 2023 | 2832 | 0.360 |
Why?
| | Diabetes, Gestational | 3 | 2023 | 321 | 0.350 |
Why?
| | Child | 31 | 2026 | 22657 | 0.350 |
Why?
| | Transcription Factors | 6 | 2024 | 1742 | 0.350 |
Why?
| | Lipid Metabolism | 4 | 2024 | 528 | 0.340 |
Why?
| | Schistosoma japonicum | 2 | 2022 | 33 | 0.340 |
Why?
| | Phylogeny | 2 | 2013 | 1019 | 0.340 |
Why?
| | Child, Preschool | 20 | 2026 | 11799 | 0.330 |
Why?
| | Support Vector Machine | 2 | 2021 | 36 | 0.330 |
Why?
| | Bias | 2 | 2022 | 202 | 0.330 |
Why?
| | Area Under Curve | 3 | 2020 | 331 | 0.320 |
Why?
| | Lung | 5 | 2023 | 4109 | 0.320 |
Why?
| | Genome, Human | 3 | 2019 | 422 | 0.310 |
Why?
| | Molybdoferredoxin | 1 | 2009 | 13 | 0.300 |
Why?
| | Binding Sites | 5 | 2021 | 1331 | 0.300 |
Why?
| | Disease Progression | 6 | 2026 | 2852 | 0.300 |
Why?
| | Autoantibodies | 5 | 2026 | 1504 | 0.300 |
Why?
| | Gastrointestinal Tract | 2 | 2022 | 208 | 0.290 |
Why?
| | Oxidoreductases | 1 | 2009 | 96 | 0.290 |
Why?
| | Infant, Newborn | 15 | 2024 | 6434 | 0.280 |
Why?
| | Adiponectin | 2 | 2024 | 244 | 0.270 |
Why?
| | Insulin | 6 | 2023 | 2507 | 0.270 |
Why?
| | Mycobacterium tuberculosis | 3 | 2016 | 337 | 0.270 |
Why?
| | Cohort Studies | 11 | 2026 | 5965 | 0.270 |
Why?
| | Signal Transduction | 7 | 2020 | 5233 | 0.260 |
Why?
| | Exons | 1 | 2008 | 358 | 0.260 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2022 | 636 | 0.250 |
Why?
| | Insulin-Like Growth Factor I | 2 | 2021 | 319 | 0.250 |
Why?
| | Leukocytes, Mononuclear | 3 | 2015 | 573 | 0.250 |
Why?
| | HIV-1 | 3 | 2022 | 896 | 0.250 |
Why?
| | Cluster Analysis | 3 | 2024 | 521 | 0.250 |
Why?
| | Alternative Splicing | 1 | 2008 | 249 | 0.240 |
Why?
| | Mice, Inbred DBA | 2 | 2019 | 187 | 0.240 |
Why?
| | Alcohol Drinking | 5 | 2014 | 826 | 0.240 |
Why?
| | Environmental Exposure | 2 | 2020 | 590 | 0.230 |
Why?
| | Middle Aged | 19 | 2026 | 35928 | 0.220 |
Why?
| | Alkanesulfonic Acids | 2 | 2023 | 49 | 0.220 |
Why?
| | Genome | 3 | 2013 | 306 | 0.220 |
Why?
| | HIV Infections | 4 | 2022 | 3154 | 0.220 |
Why?
| | Principal Component Analysis | 2 | 2023 | 198 | 0.220 |
Why?
| | Tuberculosis | 2 | 2020 | 291 | 0.220 |
Why?
| | Nasal Mucosa | 1 | 2025 | 112 | 0.220 |
Why?
| | Tuberculosis, Pulmonary | 2 | 2016 | 131 | 0.220 |
Why?
| | Soot | 1 | 2024 | 25 | 0.210 |
Why?
| | Mice, Inbred Strains | 4 | 2020 | 397 | 0.210 |
Why?
| | Quantitative Trait, Heritable | 3 | 2017 | 118 | 0.210 |
Why?
| | Aged | 14 | 2026 | 25947 | 0.210 |
Why?
| | Oxylipins | 2 | 2023 | 47 | 0.210 |
Why?
| | Carnitine O-Palmitoyltransferase | 2 | 2021 | 49 | 0.200 |
Why?
| | Melanocytes | 2 | 2015 | 65 | 0.200 |
Why?
| | Prospective Studies | 9 | 2023 | 7997 | 0.200 |
Why?
| | Severity of Illness Index | 5 | 2021 | 2925 | 0.200 |
Why?
| | Adolescent | 14 | 2026 | 22453 | 0.200 |
Why?
| | Body Mass Index | 5 | 2024 | 2438 | 0.200 |
Why?
| | Reproducibility of Results | 3 | 2021 | 3415 | 0.200 |
Why?
| | Diet | 2 | 2021 | 1275 | 0.190 |
Why?
| | Genetic Association Studies | 3 | 2020 | 373 | 0.190 |
Why?
| | Mice, Inbred C57BL | 5 | 2019 | 5997 | 0.190 |
Why?
| | Sequence Analysis, DNA | 2 | 2019 | 824 | 0.190 |
Why?
| | Genetic Variation | 3 | 2024 | 984 | 0.190 |
Why?
| | Infant | 12 | 2024 | 10039 | 0.190 |
Why?
| | Vitamin D | 1 | 2026 | 400 | 0.190 |
Why?
| | Longitudinal Studies | 7 | 2026 | 2947 | 0.190 |
Why?
| | Birth Weight | 3 | 2023 | 522 | 0.190 |
Why?
| | Somatic Hypermutation, Immunoglobulin | 1 | 2022 | 19 | 0.190 |
Why?
| | Phospholipids | 2 | 2021 | 213 | 0.180 |
Why?
| | Asthma | 2 | 2025 | 1768 | 0.180 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2023 | 142 | 0.180 |
Why?
| | Neutrophils | 2 | 2026 | 1134 | 0.180 |
Why?
| | Mothers | 3 | 2023 | 775 | 0.180 |
Why?
| | Schistosomiasis | 1 | 2022 | 49 | 0.180 |
Why?
| | CD4-Positive T-Lymphocytes | 2 | 2025 | 1129 | 0.170 |
Why?
| | Epidemiologic Studies | 1 | 2021 | 68 | 0.170 |
Why?
| | Selection Bias | 1 | 2021 | 38 | 0.170 |
Why?
| | Endemic Diseases | 1 | 2021 | 33 | 0.170 |
Why?
| | Viral Nonstructural Proteins | 1 | 2021 | 67 | 0.170 |
Why?
| | Breast Neoplasms | 3 | 2019 | 2456 | 0.170 |
Why?
| | Receptor for Advanced Glycation End Products | 1 | 2021 | 31 | 0.170 |
Why?
| | Cloud Computing | 1 | 2021 | 6 | 0.170 |
Why?
| | Air Pollutants | 2 | 2024 | 438 | 0.170 |
Why?
| | Adult | 21 | 2026 | 40506 | 0.170 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2021 | 10 | 0.170 |
Why?
| | Mitogen-Activated Protein Kinase 9 | 1 | 2021 | 17 | 0.170 |
Why?
| | Immunoglobulin A | 1 | 2022 | 214 | 0.170 |
Why?
| | Central Nervous System Depressants | 2 | 2012 | 83 | 0.170 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2021 | 40 | 0.170 |
Why?
| | Sensitivity and Specificity | 2 | 2017 | 1990 | 0.170 |
Why?
| | Normal Distribution | 2 | 2018 | 22 | 0.160 |
Why?
| | Polyadenylation | 1 | 2021 | 41 | 0.160 |
Why?
| | B-Lymphocytes | 1 | 2026 | 877 | 0.160 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2021 | 130 | 0.160 |
Why?
| | Mutation | 3 | 2021 | 4099 | 0.160 |
Why?
| | Biostatistics | 1 | 2020 | 19 | 0.160 |
Why?
| | Probability | 1 | 2021 | 312 | 0.160 |
Why?
| | Population Dynamics | 1 | 2021 | 158 | 0.160 |
Why?
| | Drug Tolerance | 1 | 2020 | 100 | 0.160 |
Why?
| | Travel | 1 | 2021 | 136 | 0.160 |
Why?
| | Interferon-beta | 1 | 2020 | 92 | 0.160 |
Why?
| | Predictive Value of Tests | 4 | 2026 | 2118 | 0.160 |
Why?
| | Monte Carlo Method | 1 | 2020 | 155 | 0.160 |
Why?
| | Discriminant Analysis | 1 | 2020 | 36 | 0.160 |
Why?
| | Least-Squares Analysis | 1 | 2020 | 76 | 0.150 |
Why?
| | Smoke | 2 | 2023 | 148 | 0.150 |
Why?
| | Genome, Viral | 1 | 2021 | 218 | 0.150 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2021 | 149 | 0.150 |
Why?
| | AMP-Activated Protein Kinases | 2 | 2020 | 191 | 0.150 |
Why?
| | Decision Trees | 1 | 2020 | 81 | 0.150 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2021 | 266 | 0.150 |
Why?
| | Premature Birth | 1 | 2023 | 380 | 0.150 |
Why?
| | Whole Genome Sequencing | 1 | 2021 | 183 | 0.150 |
Why?
| | Interferon-alpha | 1 | 2020 | 197 | 0.150 |
Why?
| | Risk Factors | 8 | 2024 | 10792 | 0.150 |
Why?
| | alpha-Macroglobulins | 1 | 2019 | 25 | 0.150 |
Why?
| | Atherosclerosis | 1 | 2023 | 409 | 0.150 |
Why?
| | Liver | 2 | 2019 | 1888 | 0.150 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 2019 | 106 | 0.150 |
Why?
| | Rats | 4 | 2023 | 5614 | 0.140 |
Why?
| | Base Sequence | 3 | 2021 | 2191 | 0.140 |
Why?
| | Sex Characteristics | 2 | 2023 | 791 | 0.140 |
Why?
| | Hypertension, Pregnancy-Induced | 1 | 2019 | 68 | 0.140 |
Why?
| | GABA-A Receptor Antagonists | 1 | 2018 | 19 | 0.140 |
Why?
| | Air Pollution | 1 | 2022 | 327 | 0.140 |
Why?
| | Reflex, Righting | 1 | 2018 | 15 | 0.140 |
Why?
| | Proteome | 1 | 2023 | 518 | 0.140 |
Why?
| | Autism Spectrum Disorder | 1 | 2023 | 412 | 0.140 |
Why?
| | Marijuana Use | 1 | 2022 | 213 | 0.140 |
Why?
| | Antiviral Agents | 2 | 2021 | 768 | 0.130 |
Why?
| | Receptor, Insulin | 1 | 2017 | 94 | 0.130 |
Why?
| | Papillomavirus E7 Proteins | 1 | 2017 | 11 | 0.130 |
Why?
| | Respiratory Mucosa | 1 | 2020 | 322 | 0.130 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2020 | 266 | 0.130 |
Why?
| | Alcohol-Related Disorders | 1 | 2018 | 120 | 0.130 |
Why?
| | Epigenomics | 2 | 2018 | 114 | 0.130 |
Why?
| | Dendritic Cells | 1 | 2020 | 499 | 0.130 |
Why?
| | Receptors, GABA-A | 1 | 2018 | 138 | 0.130 |
Why?
| | Down-Regulation | 1 | 2019 | 627 | 0.120 |
Why?
| | Chemokines | 1 | 2017 | 218 | 0.120 |
Why?
| | Forced Expiratory Volume | 3 | 2026 | 449 | 0.120 |
Why?
| | Alleles | 1 | 2019 | 881 | 0.120 |
Why?
| | Otitis Media | 1 | 2019 | 181 | 0.120 |
Why?
| | Rural Population | 1 | 2021 | 650 | 0.120 |
Why?
| | Longevity | 1 | 2017 | 173 | 0.120 |
Why?
| | Gene-Environment Interaction | 1 | 2017 | 180 | 0.120 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2018 | 228 | 0.120 |
Why?
| | Follow-Up Studies | 5 | 2026 | 5417 | 0.120 |
Why?
| | Pregnancy Outcome | 1 | 2019 | 476 | 0.120 |
Why?
| | DNA-Binding Proteins | 3 | 2019 | 1500 | 0.120 |
Why?
| | Keratinocytes | 1 | 2017 | 250 | 0.120 |
Why?
| | Age Factors | 2 | 2021 | 3335 | 0.120 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2017 | 202 | 0.120 |
Why?
| | Biomedical Research | 2 | 2020 | 710 | 0.120 |
Why?
| | High Fructose Corn Syrup | 1 | 2015 | 8 | 0.120 |
Why?
| | Corpus Luteum | 1 | 2015 | 20 | 0.120 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2018 | 196 | 0.110 |
Why?
| | Databases, Genetic | 2 | 2021 | 249 | 0.110 |
Why?
| | Plasma | 1 | 2017 | 225 | 0.110 |
Why?
| | Granulosa Cells | 1 | 2015 | 33 | 0.110 |
Why?
| | Tobacco Products | 1 | 2016 | 84 | 0.110 |
Why?
| | Cell-Derived Microparticles | 1 | 2016 | 75 | 0.110 |
Why?
| | Ultraviolet Therapy | 1 | 2015 | 17 | 0.110 |
Why?
| | Trihexosylceramides | 1 | 2015 | 4 | 0.110 |
Why?
| | Sphingomyelins | 1 | 2015 | 22 | 0.110 |
Why?
| | Adaptation, Physiological | 2 | 2016 | 570 | 0.110 |
Why?
| | Vitiligo | 1 | 2015 | 42 | 0.110 |
Why?
| | Tobacco Smoke Pollution | 1 | 2017 | 233 | 0.110 |
Why?
| | Microarray Analysis | 2 | 2012 | 117 | 0.110 |
Why?
| | Cannabis | 1 | 2022 | 509 | 0.110 |
Why?
| | Infant, Premature | 1 | 2019 | 611 | 0.110 |
Why?
| | Obesity | 4 | 2023 | 3082 | 0.110 |
Why?
| | Hair | 1 | 2015 | 88 | 0.110 |
Why?
| | Databases, Nucleic Acid | 1 | 2014 | 39 | 0.110 |
Why?
| | Molecular Sequence Data | 2 | 2009 | 2931 | 0.110 |
Why?
| | Blood Proteins | 1 | 2016 | 249 | 0.110 |
Why?
| | Hypertension, Pulmonary | 1 | 2026 | 1980 | 0.110 |
Why?
| | Child Development | 1 | 2019 | 484 | 0.100 |
Why?
| | Fatty Acids | 1 | 2017 | 452 | 0.100 |
Why?
| | Aged, 80 and over | 8 | 2021 | 8279 | 0.100 |
Why?
| | Epithelial Cells | 1 | 2020 | 1126 | 0.100 |
Why?
| | STAT2 Transcription Factor | 1 | 2013 | 3 | 0.100 |
Why?
| | 3' Untranslated Regions | 1 | 2014 | 152 | 0.100 |
Why?
| | CCCTC-Binding Factor | 1 | 2013 | 12 | 0.100 |
Why?
| | Species Specificity | 2 | 2012 | 574 | 0.100 |
Why?
| | Gangliosides | 1 | 2013 | 23 | 0.100 |
Why?
| | Gastrointestinal Microbiome | 1 | 2022 | 771 | 0.100 |
Why?
| | Drug Resistance, Bacterial | 1 | 2015 | 199 | 0.100 |
Why?
| | Saccharomyces | 1 | 2013 | 7 | 0.100 |
Why?
| | Caloric Restriction | 1 | 2015 | 127 | 0.100 |
Why?
| | G-Quadruplexes | 1 | 2013 | 25 | 0.100 |
Why?
| | Dietary Fats | 1 | 2015 | 315 | 0.100 |
Why?
| | Myocardium | 1 | 2018 | 939 | 0.100 |
Why?
| | Choice Behavior | 1 | 2014 | 178 | 0.100 |
Why?
| | Antitubercular Agents | 1 | 2015 | 216 | 0.090 |
Why?
| | Microbiota | 1 | 2021 | 781 | 0.090 |
Why?
| | Sequence Alignment | 1 | 2013 | 368 | 0.090 |
Why?
| | DNA Probes | 1 | 2012 | 59 | 0.090 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2015 | 328 | 0.090 |
Why?
| | Programming Languages | 1 | 2012 | 25 | 0.090 |
Why?
| | Heat-Shock Proteins | 1 | 2013 | 138 | 0.090 |
Why?
| | Young Adult | 8 | 2026 | 14126 | 0.090 |
Why?
| | Tretinoin | 1 | 2013 | 124 | 0.090 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2018 | 1462 | 0.090 |
Why?
| | Teratogens | 1 | 2012 | 20 | 0.090 |
Why?
| | Ultraviolet Rays | 1 | 2015 | 388 | 0.090 |
Why?
| | Proportional Hazards Models | 3 | 2021 | 1325 | 0.090 |
Why?
| | Age of Onset | 2 | 2026 | 551 | 0.090 |
Why?
| | Weight Gain | 1 | 2015 | 559 | 0.090 |
Why?
| | Fetal Alcohol Spectrum Disorders | 1 | 2012 | 70 | 0.080 |
Why?
| | Protein Binding | 2 | 2021 | 2276 | 0.080 |
Why?
| | Tomography, X-Ray Computed | 3 | 2021 | 2738 | 0.080 |
Why?
| | Regression Analysis | 3 | 2021 | 1003 | 0.080 |
Why?
| | China | 2 | 2022 | 269 | 0.080 |
Why?
| | Triglycerides | 2 | 2023 | 521 | 0.080 |
Why?
| | Chromosome Mapping | 3 | 2020 | 510 | 0.080 |
Why?
| | Pain Threshold | 1 | 2010 | 73 | 0.080 |
Why?
| | HLA-DR4 Antigen | 2 | 2021 | 74 | 0.080 |
Why?
| | Body Weight | 1 | 2015 | 978 | 0.080 |
Why?
| | HLA-DR3 Antigen | 2 | 2021 | 76 | 0.080 |
Why?
| | Stem Cells | 1 | 2015 | 627 | 0.080 |
Why?
| | Dysbiosis | 2 | 2022 | 187 | 0.080 |
Why?
| | Adrenal Cortex Hormones | 1 | 2013 | 479 | 0.080 |
Why?
| | Repressor Proteins | 1 | 2013 | 437 | 0.080 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2012 | 906 | 0.080 |
Why?
| | Cytokines | 1 | 2017 | 2065 | 0.080 |
Why?
| | Amino Acid Sequence | 2 | 2013 | 2157 | 0.070 |
Why?
| | Morphine | 1 | 2010 | 171 | 0.070 |
Why?
| | Hedgehog Proteins | 1 | 2010 | 197 | 0.070 |
Why?
| | Analysis of Variance | 1 | 2012 | 1311 | 0.070 |
Why?
| | Vital Capacity | 2 | 2021 | 290 | 0.070 |
Why?
| | Polymerase Chain Reaction | 1 | 2012 | 1054 | 0.070 |
Why?
| | Internet | 2 | 2010 | 700 | 0.070 |
Why?
| | Spirometry | 2 | 2021 | 231 | 0.070 |
Why?
| | Energy Metabolism | 1 | 2015 | 936 | 0.070 |
Why?
| | Yeasts | 1 | 2008 | 52 | 0.070 |
Why?
| | Drosophila Proteins | 1 | 2010 | 212 | 0.070 |
Why?
| | Fasting | 2 | 2023 | 277 | 0.070 |
Why?
| | Synaptic Transmission | 1 | 2010 | 290 | 0.070 |
Why?
| | Food Preferences | 1 | 2009 | 126 | 0.070 |
Why?
| | Gestational Age | 2 | 2023 | 975 | 0.070 |
Why?
| | Glycerophospholipids | 2 | 2018 | 39 | 0.070 |
Why?
| | RNA Precursors | 1 | 2008 | 156 | 0.070 |
Why?
| | Enhancer Elements, Genetic | 1 | 2008 | 192 | 0.060 |
Why?
| | Prognosis | 2 | 2026 | 4293 | 0.060 |
Why?
| | Gene Ontology | 2 | 2017 | 54 | 0.060 |
Why?
| | Folic Acid | 2 | 2019 | 199 | 0.060 |
Why?
| | Tandem Mass Spectrometry | 2 | 2021 | 577 | 0.060 |
Why?
| | Phosphorylation | 2 | 2021 | 1733 | 0.060 |
Why?
| | Uganda | 2 | 2016 | 93 | 0.060 |
Why?
| | Glucose | 2 | 2023 | 1049 | 0.050 |
Why?
| | Neoplasms | 2 | 2018 | 2884 | 0.050 |
Why?
| | Apoptosis | 1 | 2013 | 2430 | 0.050 |
Why?
| | Sputum | 2 | 2016 | 308 | 0.050 |
Why?
| | Alkanesulfonates | 1 | 2023 | 7 | 0.050 |
Why?
| | GTPase-Activating Proteins | 1 | 2023 | 82 | 0.050 |
Why?
| | Carboxylic Acids | 1 | 2023 | 34 | 0.050 |
Why?
| | Hypertrophy | 1 | 2023 | 127 | 0.050 |
Why?
| | Adipogenesis | 1 | 2023 | 57 | 0.050 |
Why?
| | Privacy | 1 | 2023 | 41 | 0.050 |
Why?
| | Cell Proliferation | 3 | 2015 | 2499 | 0.050 |
Why?
| | Models, Neurological | 1 | 2024 | 254 | 0.050 |
Why?
| | Schistosoma | 1 | 2022 | 28 | 0.050 |
Why?
| | Snails | 1 | 2022 | 37 | 0.050 |
Why?
| | Pneumonia | 2 | 2020 | 631 | 0.050 |
Why?
| | Benchmarking | 1 | 2023 | 188 | 0.040 |
Why?
| | Protein Conformation, beta-Strand | 1 | 2021 | 19 | 0.040 |
Why?
| | Protein Conformation, alpha-Helical | 1 | 2021 | 19 | 0.040 |
Why?
| | Furin | 1 | 2021 | 13 | 0.040 |
Why?
| | Asia | 1 | 2021 | 70 | 0.040 |
Why?
| | Cell Differentiation | 2 | 2023 | 2050 | 0.040 |
Why?
| | Analgesics, Opioid | 1 | 2010 | 1143 | 0.040 |
Why?
| | Granzymes | 1 | 2022 | 49 | 0.040 |
Why?
| | Adipocytes | 1 | 2023 | 223 | 0.040 |
Why?
| | Water Resources | 1 | 2021 | 8 | 0.040 |
Why?
| | Africa | 1 | 2021 | 116 | 0.040 |
Why?
| | Immunity, Humoral | 1 | 2022 | 120 | 0.040 |
Why?
| | Nerve Net | 1 | 2024 | 285 | 0.040 |
Why?
| | Molecular Docking Simulation | 1 | 2021 | 124 | 0.040 |
Why?
| | Epidemiological Monitoring | 1 | 2021 | 69 | 0.040 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 1 | 2021 | 54 | 0.040 |
Why?
| | Linoleic Acid | 1 | 2021 | 44 | 0.040 |
Why?
| | Adenosine Monophosphate | 1 | 2021 | 86 | 0.040 |
Why?
| | Cholesterol | 1 | 2023 | 408 | 0.040 |
Why?
| | Arachidonic Acid | 1 | 2021 | 101 | 0.040 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2021 | 148 | 0.040 |
Why?
| | Alanine | 1 | 2021 | 171 | 0.040 |
Why?
| | Amino Acid Substitution | 1 | 2021 | 304 | 0.040 |
Why?
| | Europe | 1 | 2021 | 412 | 0.040 |
Why?
| | Glutamate Decarboxylase | 1 | 2021 | 165 | 0.040 |
Why?
| | Docosahexaenoic Acids | 1 | 2021 | 83 | 0.040 |
Why?
| | Sex Factors | 2 | 2019 | 2114 | 0.040 |
Why?
| | Interleukin-2 | 1 | 2022 | 437 | 0.040 |
Why?
| | Systems Biology | 1 | 2021 | 72 | 0.040 |
Why?
| | Skinfold Thickness | 1 | 2020 | 43 | 0.040 |
Why?
| | Datasets as Topic | 1 | 2020 | 122 | 0.040 |
Why?
| | Nerve Tissue Proteins | 1 | 2023 | 592 | 0.040 |
Why?
| | Cattle | 1 | 2022 | 1000 | 0.040 |
Why?
| | Swine | 1 | 2022 | 833 | 0.040 |
Why?
| | Philippines | 1 | 2019 | 52 | 0.040 |
Why?
| | Workflow | 1 | 2021 | 185 | 0.040 |
Why?
| | Pakistan | 1 | 2019 | 78 | 0.040 |
Why?
| | Finland | 1 | 2019 | 79 | 0.040 |
Why?
| | Particulate Matter | 1 | 2022 | 347 | 0.040 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2020 | 120 | 0.040 |
Why?
| | Colon | 1 | 2022 | 305 | 0.040 |
Why?
| | Bronchoscopy | 1 | 2020 | 227 | 0.040 |
Why?
| | In Vitro Techniques | 1 | 2021 | 1048 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2021 | 598 | 0.040 |
Why?
| | Cigarette Smoking | 1 | 2020 | 99 | 0.040 |
Why?
| | Water | 1 | 2022 | 469 | 0.040 |
Why?
| | Gene Frequency | 1 | 2020 | 481 | 0.040 |
Why?
| | Computer Graphics | 1 | 2018 | 41 | 0.030 |
Why?
| | Early Diagnosis | 1 | 2019 | 249 | 0.030 |
Why?
| | Interleukins | 1 | 2020 | 248 | 0.030 |
Why?
| | Environmental Pollution | 1 | 2018 | 21 | 0.030 |
Why?
| | Cross-Sectional Studies | 2 | 2022 | 5872 | 0.030 |
Why?
| | Community-Acquired Infections | 1 | 2020 | 174 | 0.030 |
Why?
| | Leptin | 1 | 2019 | 245 | 0.030 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2023 | 2584 | 0.030 |
Why?
| | Pedigree | 1 | 2019 | 514 | 0.030 |
Why?
| | Adaptor Proteins, Vesicular Transport | 1 | 2018 | 44 | 0.030 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2017 | 32 | 0.030 |
Why?
| | Breast Feeding | 1 | 2021 | 448 | 0.030 |
Why?
| | Maternal Health | 1 | 2018 | 52 | 0.030 |
Why?
| | Cell Transformation, Viral | 1 | 2017 | 23 | 0.030 |
Why?
| | Evolution, Molecular | 1 | 2021 | 515 | 0.030 |
Why?
| | Caprylates | 1 | 2017 | 27 | 0.030 |
Why?
| | Epistasis, Genetic | 1 | 2017 | 66 | 0.030 |
Why?
| | Collagen | 1 | 2020 | 456 | 0.030 |
Why?
| | Umbilical Cord | 1 | 2017 | 91 | 0.030 |
Why?
| | United States | 3 | 2021 | 15988 | 0.030 |
Why?
| | Gambia | 1 | 2016 | 8 | 0.030 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 444 | 0.030 |
Why?
| | Muscle Development | 1 | 2017 | 116 | 0.030 |
Why?
| | THP-1 Cells | 1 | 2016 | 20 | 0.030 |
Why?
| | Time Factors | 2 | 2021 | 7183 | 0.030 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2020 | 451 | 0.030 |
Why?
| | Rats, Inbred SHR | 1 | 2016 | 37 | 0.030 |
Why?
| | Lod Score | 1 | 2016 | 62 | 0.030 |
Why?
| | Regulon | 1 | 2016 | 34 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2022 | 846 | 0.030 |
Why?
| | Actins | 1 | 2018 | 425 | 0.030 |
Why?
| | Nitrogen Oxides | 1 | 2016 | 54 | 0.030 |
Why?
| | Child Health | 1 | 2018 | 157 | 0.030 |
Why?
| | Antigen Presentation | 1 | 2017 | 205 | 0.030 |
Why?
| | ABO Blood-Group System | 1 | 2016 | 57 | 0.030 |
Why?
| | Granuloma | 1 | 2016 | 96 | 0.030 |
Why?
| | Logistic Models | 1 | 2021 | 2119 | 0.030 |
Why?
| | Fetal Development | 1 | 2019 | 299 | 0.030 |
Why?
| | Linkage Disequilibrium | 1 | 2016 | 247 | 0.030 |
Why?
| | Insulin Resistance | 1 | 2024 | 1241 | 0.030 |
Why?
| | Follicular Phase | 1 | 2015 | 38 | 0.030 |
Why?
| | Ovulation | 1 | 2015 | 41 | 0.030 |
Why?
| | PAX3 Transcription Factor | 1 | 2015 | 17 | 0.030 |
Why?
| | Mice, Congenic | 1 | 2015 | 23 | 0.030 |
Why?
| | Paired Box Transcription Factors | 1 | 2015 | 43 | 0.030 |
Why?
| | Molecular Sequence Annotation | 1 | 2015 | 105 | 0.030 |
Why?
| | Caenorhabditis elegans Proteins | 1 | 2017 | 210 | 0.030 |
Why?
| | Immune System | 1 | 2016 | 179 | 0.030 |
Why?
| | Hair Follicle | 1 | 2015 | 48 | 0.030 |
Why?
| | Intramolecular Oxidoreductases | 1 | 2015 | 66 | 0.030 |
Why?
| | Prevalence | 1 | 2022 | 2836 | 0.030 |
Why?
| | Bacteria | 1 | 2022 | 889 | 0.030 |
Why?
| | Latent Tuberculosis | 1 | 2015 | 71 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2015 | 72 | 0.030 |
Why?
| | Monocytes | 1 | 2017 | 538 | 0.030 |
Why?
| | Breeding | 1 | 2014 | 63 | 0.030 |
Why?
| | Mortality | 1 | 2017 | 376 | 0.030 |
Why?
| | Heart | 1 | 2018 | 636 | 0.030 |
Why?
| | Protein Kinases | 1 | 2016 | 315 | 0.030 |
Why?
| | Fetus | 1 | 2019 | 803 | 0.030 |
Why?
| | Gastroesophageal Reflux | 1 | 2017 | 236 | 0.030 |
Why?
| | Epidermis | 1 | 2015 | 157 | 0.030 |
Why?
| | Caenorhabditis elegans | 1 | 2017 | 337 | 0.030 |
Why?
| | Diet, High-Fat | 1 | 2015 | 261 | 0.030 |
Why?
| | Monophenol Monooxygenase | 1 | 2013 | 7 | 0.030 |
Why?
| | Microscopy, Phase-Contrast | 1 | 2013 | 18 | 0.020 |
Why?
| | Annexin A5 | 1 | 2013 | 21 | 0.020 |
Why?
| | Oxidation-Reduction | 1 | 2017 | 1087 | 0.020 |
Why?
| | Melanins | 1 | 2013 | 17 | 0.020 |
Why?
| | Spectrophotometry | 1 | 2013 | 61 | 0.020 |
Why?
| | Education | 1 | 2013 | 104 | 0.020 |
Why?
| | Catalase | 1 | 2013 | 130 | 0.020 |
Why?
| | Administration, Topical | 1 | 2013 | 150 | 0.020 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2013 | 396 | 0.020 |
Why?
| | Pilot Projects | 1 | 2018 | 1890 | 0.020 |
Why?
| | Blood Glucose | 1 | 2023 | 2330 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2013 | 427 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 341 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2017 | 1258 | 0.020 |
Why?
| | Structure-Activity Relationship | 1 | 2013 | 570 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2014 | 695 | 0.020 |
Why?
| | Superoxide Dismutase | 1 | 2013 | 301 | 0.020 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2014 | 259 | 0.020 |
Why?
| | GTP-Binding Protein beta Subunits | 1 | 2010 | 17 | 0.020 |
Why?
| | Receptors, GABA | 1 | 2010 | 13 | 0.020 |
Why?
| | Genetics, Behavioral | 1 | 2010 | 17 | 0.020 |
Why?
| | Thermosensing | 1 | 2010 | 12 | 0.020 |
Why?
| | Membrane Proteins | 1 | 2017 | 1167 | 0.020 |
Why?
| | Software Design | 1 | 2010 | 25 | 0.020 |
Why?
| | Crosses, Genetic | 1 | 2010 | 124 | 0.020 |
Why?
| | Cell Movement | 1 | 2015 | 965 | 0.020 |
Why?
| | Embryo, Nonmammalian | 1 | 2010 | 173 | 0.020 |
Why?
| | Cell Survival | 1 | 2013 | 1098 | 0.020 |
Why?
| | Organ Specificity | 1 | 2010 | 313 | 0.020 |
Why?
| | Colorado | 1 | 2020 | 4564 | 0.020 |
Why?
| | Endothelium, Vascular | 1 | 2016 | 965 | 0.020 |
Why?
| | Bacterial Proteins | 1 | 2016 | 962 | 0.020 |
Why?
| | Rats, Inbred Strains | 1 | 2009 | 321 | 0.020 |
Why?
| | Antioxidants | 1 | 2013 | 549 | 0.020 |
Why?
| | Models, Biological | 1 | 2017 | 1822 | 0.020 |
Why?
| | Brain Chemistry | 1 | 2009 | 116 | 0.020 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2010 | 193 | 0.020 |
Why?
| | Hypoxia | 1 | 2016 | 1199 | 0.020 |
Why?
| | Macrophages | 1 | 2016 | 1511 | 0.020 |
Why?
| | Models, Molecular | 1 | 2013 | 1619 | 0.020 |
Why?
| | Histones | 1 | 2013 | 670 | 0.020 |
Why?
| | Brain Mapping | 1 | 2010 | 537 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 6053 | 0.020 |
Why?
| | Curriculum | 1 | 2013 | 1060 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2014 | 3550 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2013 | 4155 | 0.010 |
Why?
| | Antineoplastic Agents | 1 | 2014 | 2197 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2009 | 4569 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2017 | 17101 | 0.010 |
Why?
|
|
Kechris's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|